Investigation of the inhibitory mechanism of apomorphine against MDM2–p53 interaction

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

Inhibiting HIV-1 Entry

Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442 · see citing works

Mirror-image RNA that binds D-adenosine

Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 397 · see citing works

Identification of d -Peptide Ligands Through Mirror-Image Phage Display

Schumacher, T. N., Mayr, L. M., Minor, D. L., Milhollen, M. A., Burgess, M. W., & Kim, P. S. (1996) · Science · doi:10.1126/science.271.5257.1854 · Cited by 377 · see citing works

Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics

Vater, A., & Klußmann, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.004 · Cited by 251 · see citing works

Potent D-peptide inhibitors of HIV-1 entry

Welch, B. D., VanDemark, A. P., Heroux, A., Hill, C. P., & Kay, M. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708109104 · Cited by 250 · see citing works

D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

Liu, M., Li, C., Pazgier, M., Li, C., Mao, Y., Lv, Y., Gu, B., Wei, G., Yuan, W., Zhan, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008930107 · Cited by 229 · see citing works

Bioactive and nuclease-resistant l -DNA ligand of vasopressin

Williams, K. P., Liu, X., Schumacher, T. N., Lin, H. Y.-F., Ausiello, D. A., Kim, P. S., & Bartel, D. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11285 · Cited by 222 · see citing works

Mirror-design of L-oligonucleotide ligands binding to L-arginine

Nolte, A., Klußmann, S., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1116 · Cited by 206 · see citing works

Selection of D ‐Amino‐Acid Peptides That Bind to Alzheimer's Disease Amyloid Peptide Aβ 1–42 by Mirror Image Phage Display

Wiesehan, K., Buder, K., LINKE, R. P., Patt, S., Stoldt, M., Unger, E., Schmitt, B., Bucci, E. M., & Willbold, D. (2003) · ChemBioChem · doi:10.1002/cbic.200300631 · Cited by 171 · see citing works

Immobilization of Natural Products on Glass Slides by Using a Photoaffinity Reaction and the Detection of Protein–Small‐Molecule Interactions

Kanoh, N., Kumashiro, S., Simizu, S., Kondoh, Y., Hatakeyama, S., Tashiro, H., & Osada, H. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352164 · Cited by 154 · see citing works

Reduction of Alzheimer’s Disease Amyloid Plaque Load in Transgenic Mice by D3, a D ‐Enantiomeric Peptide Identified by Mirror Image Phage Display

van Groen, T., Wiesehan, K., Funke, S. A., Kadish, I., Nagel‐Steger, L., & Willbold, D. (2008) · ChemMedChem · doi:10.1002/cmdc.200800273 · Cited by 129 · see citing works

A Left‐Handed Solution to Peptide Inhibition of the p53–MDM2 Interaction

Liu, M., Pazgier, M., Li, C., Yuan, W., Li, C., & Lu, W. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000329 · Cited by 115 · see citing works

GnRH Binding RNA and DNA Spiegelmers

Leva, S., Lichte, A., Burmeister, J., Muhn, P., Jahnke, B., Fesser, D., Erfurth, J., Burgstaller, P., & Klußmann, S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00111-4 · Cited by 94 · see citing works

Mirror image phage display—a method to generate d -peptideligands for use in diagnostic or therapeutical applications

Funke, S. A., & Willbold, D. (2009) · Molecular BioSystems · doi:10.1039/b904138a · Cited by 86 · see citing works

Mirror‐image Phage Display: Aiming at the Mirror

Wiesehan, K., & Willbold, D. (2003) · ChemBioChem · doi:10.1002/cbic.200300570 · Cited by 72 · see citing works

Mirror image proteins

Zhao, L., & Lu, W. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.019 · Cited by 62 · see citing works

On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53

Bista, M., Smithson, D., Pecak, A., Salinas, G., Pustelny, K., Min, J., Pirog, A., Finch, K., Zdzalik, M., Waddell, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037518 · Cited by 58 · see citing works

Electrochemical studies of the oxidation pathways of apomorphine

Cheng, H., Strope, E. R., & Adams, R. N. (1979) · Analytical Chemistry · doi:10.1021/ac50049a042 · Cited by 40 · see citing works

Interactions of Apomorphine with Serum and Tissue Proteins

Smith, R. V., Velagapudi, R. B., McLean, A. M., & Wilcox, R. E. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm50001a014 · Cited by 27 · see citing works

New insights into the oxidation pathways of apomorphine

Garrido, J. M. P. J., Delerue-Matos, C. M., Borges, F., Macedo, T. R. A., & Oliveira‐Brett, A. M. (2002) · Journal of the Chemical Society Perkin Transactions 2 · doi:10.1039/b204605a · Cited by 24 · see citing works

Affinity-based screening of MDM2/MDMX–p53 interaction inhibitors by chemical array: Identification of novel peptidic inhibitors

Noguchi, T., Oishi, S., Honda, K., Kondoh, Y., Saito, T., Kubo, T., Kaneda, M., Ohno, H., Osada, H., & Fujii, N. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.094 · Cited by 24 · see citing works

Screening of a virtual mirror-image library of natural products

Noguchi, T., Oishi, S., Honda, K., Kondoh, Y., Saito, T., Ohno, H., Osada, H., & Fujii, N. (2016) · Chemical Communications · doi:10.1039/c6cc03114e · Cited by 22 · see citing works

Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems

Noguchi, T., Ishiba, H., Honda, K., Kondoh, Y., Osada, H., Ohno, H., Fujii, N., & Oishi, S. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00692 · Cited by 20 · see citing works

A Fluorescent-Based High-Throughput Screening Assay for Small Molecules That Inhibit the Interaction of MdmX with p53

Tsuganezawa, K., Nakagawa, Y., Kato, M., Taruya, S., Takahashi, F., Endoh, M., Utata, R., Mori, M., Ogawa, N., Honma, T., et al. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112460729 · Cited by 19 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

The design and development of covalent protein-protein interaction inhibitors for cancer treatment

Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98 · see citing works

Itaconic acid derivatives: structure, function, biosynthesis, and perspectives

Sano, M., Tanaka, T., Ohara, H., & Aso, Y. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10908-1 · Cited by 62 · see citing works

Elevation of hepatic autophagy and antioxidative capacity by endurance exercise is associated with suppression of apoptosis in mice

Kwon, I., Song, W., Jang, Y., Choi, M. D., Vinci, D. M., & Lee, Y. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.08.010 · Cited by 35 · see citing works

3′,4′-Dihydro-2′H-spiro[indoline-3,1′-isoquinolin]-2-ones as potential anti-cancer agents: synthesis and preliminary screening

Lobe, M. M. M., & Efange, S. M. N. (2020) · Royal Society Open Science · doi:10.1098/rsos.191316 · Cited by 21 · see citing works

New tricks for an old dog: A repurposing approach of apomorphine

Auffret, M., Drapier, S., & Vérin, M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.052 · Cited by 21 · see citing works

Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer

Bhatia, N., Khator, R., Kulkarni, S., Singh, Y., Kumar, P., & Thareja, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221114103924 · Cited by 18 · see citing works

Apomorphine induces mitochondrial-dysfunction-dependent apoptosis in choriocarcinoma

Lee, J., Ham, J., Lim, W., & Song, G. (2020) · Reproduction · doi:10.1530/rep-20-0230 · Cited by 10 · see citing works

Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity

Rodrigues‐Junior, D. M., Raminelli, C., Hassanie, H., Trossini, G. H. G., Perecim, G. P., Caja, L., Moustakas, A., & Vettore, A. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-25534-2 · Cited by 7 · see citing works

Covalent Protein Inhibitors via Tyrosine Conjugation with Cyclic Imine Mannich ElectrophilesPreprint

Wang, S., Hadisurya, M., Tao, W. A., Dykhuizen, E. C., & Krusemark, C. J. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-tvgn1 · Cited by 4 · see citing works

Comparative Dynamic Features of Apo and Bound MDM2 Protein Reveal the Mechanism of Inhibitor Recognition for Anti-Cancer Activity

habbash, A. I. E., Ahmed, E., & Soliman, M. E. S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220610194919 · Cited by 2 · see citing works

Development of a Mirror-Image Screening System for Chiral Natural Products

Noguchi, T. (2017) · Springer theses · doi:10.1007/978-981-10-6623-8_2

Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres

González, A. Z., Li, Z., Beck, H. P., Canon, J. R., Chen, A., Chow, D. T., Duquette, J., Eksterowicz, J. E., Fox, B. M., Fu, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401911v · Cited by 58 · see citing works

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Rew, Y., Sun, D., de Turiso, F. G.-L., Bartberger, M. D., Beck, H. P., Canon, J. R., Chen, A., Chow, D. T., Deignan, J., Fox, B. M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300354j · Cited by 166 · see citing works

Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction

Allen, J. G., Bourbeau, M. P., Wohlhieter, G. E., Bartberger, M. D., Michelsen, K., Hungate, R. W., Gadwood, R. C., Gaston, R. D., Evans, B., Mann, L. W., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900681h · Cited by 148 · see citing works